The Mesothelioma Applied Research Foundation (MARF) has announced that it has awarded an additional $1 million in research funding aimed at curing the asbestos-related cancer known as mesothelioma, according to a press released issued by the foundation.

“In the past few years,” states the press release, “meso science has begun to progress rapidly, and there is now new hope for meso patients and those at risk. Researchers are discovering the particular genes and proteins involved in the disease. This is enabling development of powerful biomarkers, which can aid in detecting and monitoring the cancer. It also offers promise for development of targeted therapies, aimed at controlling the pathways that turn a normal cell into meso.”

MARF has supported such research since 1999. “Thanks to generous donors, this is now the third year in a row in which we have been able to support critically-needed meso research at the million-dollars-per- year level,” noted executive director Chris Hahn. “This consistent support is enabling brilliant investigators around the world to invest their careers in meso, and to pursue the detailed scientific studies needed to develop effective treatments. As a result, we are seeing the whole field make great strides forward.”

This entry was posted on Tuesday, March 20th, 2007 at 9:07 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.